Authors
Latest:
Process of Care Compliance Is Associated With Fewer Diabetes ComplicationsAdherence to process of care measures was associated with reduced risk of 2 diabetes complications or any of 4 complications in a national industrial cohort.
Latest:
Survival and Cost-Effectiveness of Hospice Care for Metastatic Melanoma PatientsHospice care is associated with improved median survival time for the patients diagnosed with metastatic melanoma, accompanied by decreased end-of-life costs.
Latest:
Sofosbuvir Initial Therapy Abandonment and Manufacturer Coupons in a Commercially Insured PopulationMember cost negatively affects initial medication adherence and manufacturer coupons can decrease member share by up to 98%.
Latest:
Understanding the Relationship Between Data Breaches and Hospital Advertising ExpendituresA hospital data breach was associated with a 64% increase in annual advertising expenditures.
Latest:
Telemetry: Appropriateness of Initial Assignment and Duration in Nonintensive SettingThe authors report overutilization of telemetry monitoring in a community setting, increasing the cost of health care and potential harm to patients with unnecessary interventions.
Latest:
Racial and Ethnic Disparity in Palliative Care and Hospice UseRace/ethnicity was not a predictor of inpatient palliative care consultation or discharge to hospice in 4 hospitals with an inpatient palliative care service.
Latest:
Health Economic Analysis of Breast Cancer Index in Patients With ER+, LN- Breast CancerThis study projected that the breast cancer index assay is cost saving when used either at diagnosis or at 5 years post diagnosis.
Latest:
The Value of Novel Immuno-Oncology TreatmentsThis study assesses the value of novel immuno-oncology treatments to society.
Latest:
Efficiency and Its Measurement: What Practitioners Need to KnowStakeholders in US healthcare are increasingly seeking to measure and improve efficiency. This article describes an efficiency concept and some practical measurement challenges.
Latest:
A Narrow View of Choosing WiselyThis letter argues that an editorial published in the August 2018 issue provides an unduly limited perspective of the impact of Choosing Wisely.
Latest:
Who Should We Treat: Elective Surgical Admissions or Patients With COVID-19?In the midst of the coronavirus disease 2019 (COVID-19) pandemic, health care leaders must work to optimize emergency department and hospital efficiency while maintaining patient access to care.
Latest:
Addressing Oncologists' Gaps in the Use of Biosimilar ProductsThe availability of biosimilar products may improve access to healthcare by increasing the number of therapeutic options available at potentially lower costs. As of April 2019, 18 such biological products had been approved by the FDA, including 4 biosimilars for trastuzumab, 3 each for infliximab and adalimumab, 2 each for pegfilgrastim and filgrastim, and 1 each for rituximab, epoetin alfa, bevacizumab, and etanercept. The pace of approvals has accelerated, from the first indication for a filgrastim biosimilar in 2015 to 3 approvals in 2016, 5 in 2017, and 9 through early 2019, 7 of which were announced in the 2018 calendar year.
Latest:
Dialing In: Effect of Telephonic Wellness Coaching on Weight LossSmall weight loss was reported by overweight/obese individuals targeted for telephonic wellness coaching in this large retrospective study using pre-post design.
Latest:
Comparison of Healthcare Utilization Among Patients Treated With Alcoholism MedicationsTreatment of alcohol dependence with medications offered advantages in reduced healthcare utilization and costs compared with usual treatment without medications.
Latest:
Impact of Care Coordination Based on Insurance and Zip CodeA care transitions program for patients who underwent percutaneous coronary intervention appeared to reduce 30-day rehospitalizations for patients with Medicaid who lived in wealthier zip codes.
Latest:
Insurers’ Perspectives on MA Value-Based Insurance Design ModelThis article describes perspectives of Medicare Advantage (MA) insurers about participating in the CMS value-based insurance design model test launched in 2017.
Latest:
Insurers’ Perspectives on MA Value-Based Insurance Design ModelThis article describes perspectives of Medicare Advantage (MA) insurers about participating in the CMS value-based insurance design model test launched in 2017.
Latest:
Advancing the Learning Health System by Incorporating Social DeterminantsWithout integrating data on the social determinants of health, the learning health system could fail to reach its mission of higher-quality, safer, and more efficient care.
